Loading company…
ID 405138300 · FY 2018–2024 · 7 years
კომპანიის ძირითად საქმიანობას წარმოადგენს მედიკამენტებით და სამედიცინო სახარჯი მასალებით საბითუმო ვაჭრობა.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,362 | 2,372 | 3,337 | 4,491 | 4,855 | 4,312 | 5,423 | +14.9% |
| Total COGS | -1,539 | -1,629 | -2,330 | -3,082 | -3,318 | -2,756 | -3,546 | +14.9% |
| Gross Profit | 822 | 743 | 1,007 | 1,410 | 1,537 | 1,556 | 1,877 | +14.7% |
| Gross Margin | 34.8% | 31.3% | 30.2% | 31.4% | 31.7% | 36.1% | 34.6% | |
| Total Operating Expenses | -338 | -354 | -321 | -350 | -549 | -447 | -500 | +6.7% |
| EBITDA | 484 | 389 | 686 | 1,060 | 988 | 1,110 | 1,377 | +19.0% |
| EBITDA Margin | 20.5% | 16.4% | 20.6% | 23.6% | 20.4% | 25.7% | 25.4% | |
| Total D&A | -5 | -8 | -5 | -5 | -7 | -5 | -6 | +2.2% |
| EBIT / Operating Income | 479 | 381 | 681 | 1,055 | 981 | 1,104 | 1,372 | +19.2% |
| Total Interest Expense | 0 | 0 | -58 | -38 | -13 | -0 | -0 | nmf |
| Total Other Income | 0 | -18 | -29 | 40 | 30 | 24 | -33 | nmf |
| Profit Before Tax | 480 | 363 | 594 | 1,056 | 998 | 1,128 | 1,339 | +18.7% |
| Total Income Tax | -22 | -93 | -72 | 0 | 0 | -69 | -62 | +18.6% |
| Net Profit / (Loss) | 457 | 270 | 522 | 1,056 | 1,011 | 1,046 | 1,275 | +18.7% |
| Net Margin | 19.3% | 11.4% | 15.6% | 23.5% | 20.8% | 24.3% | 23.5% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).